Gastric bypass surgery has been highlighted as a significantly more effective treatment than gastric sleeve surgery for individuals with type 2 diabetes, aiming for remission, even in cases of subsequent weight gain. This was the conclusion of a new study published in the Journal of the American College of Surgeons, which underscored the enduring benefits of gastric bypass surgery in diabetes management.
The research, conducted by the Mayo Clinic in Minnesota, analyzed the medical records of 270 participants who underwent weight loss surgery between 2008 and 2017. This group included 224 individuals who had gastric bypass surgery and 46 who received a gastric sleeve procedure. All participants were diagnosed with obesity and type 2 diabetes prior to their surgeries. The study’s focus was to investigate whether weight regain after surgery influenced the recurrence of diabetes over a minimum follow-up period of five years.
Key findings from the study revealed a stark contrast in the effectiveness of the two types of surgeries in managing type 2 diabetes. Specifically, 75% of the gastric bypass group experienced sustained diabetes remission five years post-surgery, compared to only 34% in the sleeve gastrectomy group. Remarkably, among those who underwent gastric bypass and regained significant weight, about 60% continued to maintain diabetes remission. In contrast, no participants in the gastric sleeve group who regained weight managed to sustain their remission.
The study highlighted several factors more closely associated with diabetes recurrence, including insulin use, higher A1C levels before surgery, and a longer duration of type 2 diabetes before undergoing the procedure. These findings suggest that factors beyond weight regain play a crucial role in the long-term management of type 2 diabetes.
Gastric bypass surgery involves reducing the size of the stomach and rerouting the upper part of the small intestine, unlike the gastric sleeve procedure, which merely reduces the stomach’s size without altering the intestinal pathway. This distinction is crucial, as the bypassed portion of the small intestine has a significant role in diabetes remission, indicating a weight loss-independent effect on diabetes and metabolism.
Experts not involved in the study, such as Dr. Christine Ren-Fielding from NYU Langone Health and Dr. Mir Ali from MemorialCare Surgical Weight Loss Center, echoed the findings, emphasizing the superiority of gastric bypass surgery for diabetes management. They pointed out the critical role of the small intestine in this process and highlighted the surgery’s potential to keep diabetes in remission, even in the face of weight regain.
The study’s implications extend beyond the immediate benefits of diabetes remission, suggesting an increased life expectancy for individuals with obesity who undergo gastric bypass surgery. Although the research faces limitations, such as its retrospective nature and the inability to account for lifestyle factors, its findings offer a promising outlook for the future of diabetes treatment and management, reinforcing the pivotal role of gastric bypass surgery in achieving long-term remission of type 2 diabetes.
Journal Reference – Surgery, a D. of. (n.d.). Continued Diabetes Remission Despite Weight Recurrence:… : Journal of the American College of Surgeons. Retrieved from https://journals.lww.com/journalacs/abstract/9900/continued_diabetes_remission_despite_weight.806.aspx
